期刊文献+

基因编辑婴儿的伦理、法律和社会蕴含 被引量:6

Ethical, legal and social implications of germline gene editing babies
原文传递
导出
摘要 同试管婴儿、克隆人、商业化代孕、干细胞治疗等医疗新技术引发的伦理争议相比,贺建奎基因编辑婴儿事件引发的关注更大、社会反响更为猛烈。探讨贺建奎基因编辑婴儿事件引发国际国内热议的原因,讨论了基因编辑婴儿的伦理、法律和社会蕴含。建议明确界定基因编辑技术的适用对象和范围,建立健全新型医疗技术临床应用的伦理审查和监管体系,提升全社会的伦理意识。 He Jiankui’s event of genome editing infant has attracted more attention than other novel medical technologies such as IVF,human cloning, commercial surrogacy, stem cell therapy, and brain-machine interface. This paper discusses the reasons of the great influence of this event, as well as the ethical, legal and social implications of genome editing infant. This paper proposes that the applicable objects and the scopes of germline gene editing technology should be clearly defined;the state should accelerate the establishment and improvement of an ethical review and supervision system for the clinical application of novel medical technologies;and the ethical consciousness of the whole society need to be highly emphasized.
作者 林玲 张新庆 LIN Ling;ZHANG Xinqing(School of Humanities and Social Sciences,Peking Union Medical College,Beijing 100730,China)
出处 《科技导报》 CAS CSCD 北大核心 2019年第6期13-18,共6页 Science & Technology Review
基金 国家自然科学基金项目(L1824002)
关键词 基因编辑婴儿 伦理蕴含 医疗监管 germline gene editing babies ethical implication medical oversight
  • 相关文献

参考文献3

二级参考文献14

  • 1王临虹,王爱玲,方利文,苏穗青,乔亚萍.艾滋病母婴传播的流行状况与预防[J].中国妇幼保健,2005,20(3):350-352. 被引量:113
  • 2王爱玲,乔亚萍,苏穗青,王临虹.艾滋病感染孕产妇接受预防艾滋病母婴传播措施情况及对策分析[J].中国妇幼保健,2006,21(13):1765-1766. 被引量:41
  • 3毛雪梅,王淸,杨红俊.云南省某市结婚登记人群HIV感染现 状及人口学特征[J].中国保健,2010 , 07.07 : 24.
  • 4Lanphier E, Urnov F, Haecker SE, Werner M, Smolenski J. Don't edit the human germ line. Nature,2015,519(7544):410-1. doi: 10.1038/519410a.
  • 5Liang P,Xu Y, Zhang X, Ding C, Huang R, Zhang Z, Lv J, Xie X, Chen Y, Li Y et al. CRISPR/Cas9-mediated gene editing in human tripronuelear zygotes. Protein Cei1,2015 ,6(5):363-72. doi: 10.1007/s13238 015-0153-5.
  • 6Bosley KS, Botchan M, Bredenoord AL, et. al. CRISPR germline engineering-the community speaks. NatBiotechnol, 2015 ,33(5):478-86. doi: 10.1038/nbt. 3227.
  • 7Xiang Kang, Wenyin He, Yuling Huang, Qian Yu, Yaoyong Chen, Xingcheng Gao, Xiaofang Sun, Yongfan. Introducing precise genetic modification into human 3PN embryo by CRISPR/Cas-mediated genome editing. J Assist Reprod Genet, 2016 Apr 6. [Epub ahead of print].
  • 8Niklaus H. Evitt, Shamik Mascharak, and Russ B. Altman. Human Germline CRISPR-Cas Modification: Toward a Regulatory Framework. Am J Bioeth, 2015,15 (12) : 25-29.
  • 9Caplan A, Levine B. Hope. hype and help: ethically assessing the growing market in stem cell therapies. Am J Bioeth, 2010 May;10(5) :24.
  • 10R. Alta Char0. On the Road (to a Cure?) Stem-Cell Tourism and Lessons for Gene Editing. N EnglJ Med,2016,374:901-903.

共引文献31

同被引文献56

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部